忍者ブログ
Informative and Instructive Science News
[8]  [9]  [10]  [11]  [12]  [13]  [14]  [15]  [16]  [17]  [18
×

[PR]上記の広告は3ヶ月以上新規記事投稿のないブログに表示されています。新しい記事を書く事で広告が消えます。

The future of futurology

Think small, think short—and listen

SO THERE you are on the moon, reading The World in 2008 on disposable digital paper and waiting for the videophone to ring. But no rush, because you’re going to live for ever—and if you don’t, there’s a backed-up copy of your brain for downloading to your clone.

Yes? No? Well, that’s how the 21st century looked to some futurologists 40 or 50 years ago, and they’re having a hard time living it down now. You can still get away (as we do) with predicting trends in the world next year, but push the timeline out much further, and you might as well wear a T-shirt saying “crackpot”. Besides, since the West began obsessing a generation ago about accelerating social and technological change, people in government and industry can spend weeks each year in retreats brainstorming and scenario-building about the future of their company or their industry or their world. The only thing special about a futurologist is that he or she has no other job to do.

Small wonder that futurology as we knew it 30 or 40 years ago—the heyday of Alvin Toffler’s “Future Shock”, the most popular work of prophecy since Nostradamus—is all but dead. The word “futurologist” has more or less disappeared from the business and academic world, and with it the implication that there might be some established discipline called “futurology”. Futurologists prefer to call themselves “futurists”, and they have stopped claiming to predict what “will” happen. They say that they “tell stories” about what might happen. There are plenty of them about, but they have stopped being famous. You have probably never heard of them unless you are in their world, or in the business of booking speakers for corporate dinners and retreats.

We can see now that the golden age of blockbuster futurology in the 1960s and 1970s was caused, not by the onset of profound technological and social change (as its champions claimed), but by the absence of it. The great determining technologies—electricity, the telephone, the internal combustion engine, even manned flight—were the products of a previous century, and their applications were well understood. The geopolitical fundamentals were stable, too, thanks to the cold war. Futurologists extrapolated the most obvious possibilities, with computers and nuclear weapons as their wild cards. The big difference today is that we assume our determining forces to be ones that 99% of us do not understand at all: genetic engineering, nanotechnology, climate change, clashing cultures and seemingly limitless computing power. When the popular sense of direction is baffled, there is no conventional wisdom for futurologists to appropriate or contradict.

Popcorn and prediction markets

There are still some hold-outs prophesying at the planetary level: James Canton, for example, author of “Extreme Future”. But the best advice for aspirant futurists these days is: think small. The best what-lies-ahead book of 1982 was “Megatrends”, by John Naisbitt, which prophesied the future of humanity. A quarter-century later, its counterpart for 2007 was “Microtrends”, by Mark Penn, a public-relations man who doubles as chief strategy adviser to Hillary Clinton’s 2008 presidential campaign. “Microtrends” looks at the prospects for niche social groups such as left-handers and vegan children. The logical next step would be a book called “Nanotrends”, save that the title already belongs to a journal of nano-engineering.

The next rule is: think short-term. An American practitioner, Faith Popcorn, showed the way with “The Popcorn Report” in 1991, applying her foresight to consumer trends instead of rocket science. The Popcornised end of the industry thrives as an adjunct of the marketing business, a research arm for its continuous innovation in consumer goods. One firm, Trendwatching of Amsterdam, predicts in its Trend Report for 2008 a list of social fads and niche markets including “eco-embedded brands” (so green they don’t even need to emphasise it) and “the next small thing” (“What happens when consumers want to be anything but the Joneses?”).

A third piece of advice: say you don’t know. Uncertainty looks smarter than ever before. Even politicians are seeing the use of it: governments that signed the Kyoto protocol on climate change said, in effect: “We don’t know for sure, but best to be on the safe side”—and they have come to look a lot smarter than countries such as America and Australia which claimed to understand climate change well enough to see no need for action.

The last great redoubt of the know-alls has been the financial markets, hedge funds claiming to have winning strategies for beating the average. But after the market panic of 2007 more humility is to be expected there too.

A fourth piece of advice for the budding futurist: get embedded in a particular industry, preferably something to do with computing or national security or global warming. All are fast-growing industries fascinated by uncertainty and with little use for generalists. Global warming, in particular, is making general-purpose futurology all but futile. When the best scientists in the field say openly that they can only guess at the long-term effects, how can a futurologist do better? “I cannot stop my life to spend the next two or ten years to become an expert on the environment,” complains Mr Naisbitt in his latest book, “Mindset” (although the rewards for Al Gore, who did just that, have been high).

A fifth piece of advice: talk less, listen more. Thanks to the internet, every intelligent person can amass the sort of information that used to need travel, networking, research assistants, access to power. It is no coincidence that the old standard work on herd instinct, Charles Mackay’s “Extraordinary Popular Delusions and the Madness of Crowds”, has been displaced by James Surowiecki’s “The Wisdom of Crowds”.

The most heeded futurists these days are not individuals, but prediction markets, where the informed guesswork of many is consolidated into hard probability. Will Osama bin Laden be caught in 2008? Only a 15% chance, said Newsfutures in mid-October 2007. Would Iran have nuclear weapons by January 1st 2008? Only a 6.6% chance, said Inkling Markets. Will George Bush pardon Lewis “Scooter” Libby? A better-than-40% chance, said Intrade. There may even be a prediction market somewhere taking bets on immortality. But beware: long- and short-sellers alike will find it hard to collect.

PR
Both Sides Cite Science to Address Altered Corn

The environmental commissioner, Stavros Dimas, said he had based his decision squarely on scientific studies suggesting that long-term uncertainties and risks remain in planting the so-called Bt corn. But when the full European Commission takes up the matter in the next couple of months, commissioners will have to decide what mix of science, politics and trade to apply. And they will face the ambiguous limits of science when it is applied to public policy.

For a decade, the European Union has maintained itself as the last big swath of land that is mostly free of genetically modified organisms, largely by sidestepping tough questions. It kept a moratorium on the planting of crops made from genetically altered seeds while making promises of further scientific studies.

But Europe has been under increasing pressure from the World Trade Organization and the United States, which contend that there is plenty of research to show such products do not harm the environment. Therefore, they insist, normal trade rules must apply.

Science does not provide a definitive answer to the question of safety, experts say, just as science could not determine beyond a doubt how computer clocks would fare at the turn of the millennium.

“Science is being utterly abused by all sides for nonscientific purposes,” said Benedikt Haerlin, head of Save Our Seeds, an environmental group in Berlin and a former member of the European Parliament. “The illusion that science will answer this overburdens it completely.” He added, “It would be helpful if all sides could be frank about their social, political and economic agendas.”

Mr. Dimas, a lawyer and the minister from Greece, looked at the advice provided by the European Union’s scientific advisory body — which found that the corn was “unlikely” to pose a risk — but he decided there were nevertheless too many doubts to permit the modified corn.

“Commissioner Dimas has the utmost faith in science,” said Barbara Helfferich, spokeswoman for the environment department. “But there are times when diverging scientific views are on the table.” She added that Mr. Dimas was acting as a “risk manager.”

Within the European scientific community, there are passionate divisions about how to apply the growing body of research concerning genetically modified crops, and in particular Bt corn. That strain is based on the naturally occurring soil bacterium Bacillus thuringiensis and mimics its production of a toxin to kill pests. The vast majority of research into such crops is conducted by, or financed by, the companies that make seeds for genetically modified organisms.

“Where everything gets polarized is the interpretation of results and how they might translate into different scenarios for the future,” said Angelika Hilbeck, an ecologist at the Swiss Federal Institute of Technology in Zurich, whose skeptical scientific work on Bt corn was cited by Mr. Dimas. “Is the glass half-empty or half-full?” she asked.

Ms. Hilbeck says that company-financed studies do not devote adequate attention to broad ripple effects that modified plants might cause, like changes to bird species or the effect of all farmers planting a single biotechnology crop. She said producers of modified organisms, like Syngenta and Monsanto, have rejected repeated requests to release seeds to researchers like herself to conduct independent studies on their effect on the environment.

In his decision, Mr. Dimas cited a dozen scientific papers in finding potential hazards in the Bt corn to butterflies and other insects.

But the European Federation of Biotechnology, an industry group, contends that the great majority of these papers show that Bt corn does not pose any environmental risk.

Many plant researchers say that Mr. Dimas ignored scientific conclusions, including those of several researchers who advised the European Union that the new corn was safe.

“We are seeing ‘advice-resistant’ politicians pursuing their own agendas,” said one researcher, who like others asked not to be identified because of his advisory role.

But Karen S. Oberhauser, a leading specialist on monarch butterflies at the University of Minnesota, said that debate and further study of Bt corn was appropriate, particularly for Europe.

“We don’t really know for sure if it’s having an effect” on ecosystems in the United States, she said, and it is hard to predict future problems. About 40 percent of corn in the United States is now the Bt variety, and it has been planted for about a decade.

“Whether Bt corn is a problem depends totally on the ecosystem — what plants are near the corn field and what insects feed on them,” Ms. Oberhauser said. “So it’s really, really important to have careful studies.”

Bt crops produce a toxin that kills pests but is also toxic to related insects, notably monarch butterflies and a number of water insects. The butterflies do not feed on corn itself, but they might feed nearby, on plants like milkweed. Because corn pollen is carried in the wind, such plants can become coated with Bt pollen.

Ms. Oberhauser said she had been worried about the effect of Bt corn on monarch butterflies in the United States after her studies showed that populations of the insect dipped from 2002 to 2004. But they have rebounded in the last three years, and she has concluded that, in the American Corn Belt, Bt corn has probably not hurt monarch butterflies.

Still, she said there was disagreement about that as well as broader causes for worry. Monarch butterflies may have been saved in the United States, she said, by a fluke of local farming practices. Year by year, farmers alternate Bt corn with a genetically modified soy seed that requires the use of a weed killer. That weed killer, Monsanto’s Roundup, eliminated milkweed — the monarch’s favored meal — in and around corn fields, so the butterflies went elsewhere and were no longer exposed to Bt.

“It’s a problem for milkweed, but it made the risk for monarchs very small,” she said.

Still, she said, other effects could emerge with time and in farming regions with other practices. For example, Bt toxin slows the maturation of butterfly caterpillars, which leaves them exposed to predators for longer periods.

“Sure, time will give you answers on these questions — and maybe show you mistakes that you should have thought about earlier,” she said.

For ecologists and entomologists, a major concern is that insects could quickly become resistant to the toxin built into the corn if all farmers in a region used that corn, just as microbes affecting humans become resistant to antibiotics that are prescribed often. The pests that are killed by modified corn are only a sporadic problem and could be treated by other means.

Scientists also worry about collateral damage because Bt toxin is in wind-borne pollen. Most pollens “are highly nutritious, as they are designed to attract,” Ms. Hilbeck said, wondering how a toxic pollen would affect bees, for example.

Having reviewed the science, insurance companies have been unwilling to insure Bt planting because the risks to people and the environment are too uncertain, said Duncan Currie, an international lawyer in Christchurch, New Zealand, who studies the subject.

In the United States, where almost all crops are now genetically modified, the debate is largely closed.

“I’m not saying there are no more questions to pursue, but whether it’s good or bad to plant Bt corn — I think we’re beyond that,” said Richard L. Hellmich, a plant scientist with the Agriculture Department who is based at Iowa State University. He noted that hundreds of studies had been done and that Bt corn could help “feed the world.”

But the scientific equation may look different in Europe, with its increasing green consciousness and strong agricultural traditions.

“Science doesn’t say on its own what to do,” said Catherine Geslain-Lanéelle, executive director of the European Food Safety Authority. She noted that while her agency had advised Mr. Dimas that Bt corn was “unlikely” to cause harm, it was still working to improve its assessment of the long-term risk to the environment.

Part of the reason that science is central to the current debate is that European law and World Trade Organization rules make it much easier for a country or a region to exclude genetically modified seeds if new scientific evidence indicates a risk. Lacking that kind of justification, a move to bar the plants would be regarded as an unfair barrier to trade, leaving the European Union open to penalties.

But the science probably will not be clear-cut enough to let the European ministers avoid that risk.

Simon Butler at the University of Reading in Britain is using computer models to predict the long-term effect of altered crops on birds and other species. But should the ministers reject Bt and other genetically modified corn?

“My work is not to judge whether G.M. is right or wrong,” he said. “It’s just to get the data out there.”

A medicine hunter on a remote path to cures

Cesar Rosales with a herbal product in Lima, Peru, meant to purify the liver. Such remedies in Peru often date back thousands of years. A traditional method is used to shake dirt from a batch of a popular root vegetable, maca. 

High in the Peruvian Andes, a shaman rubs a fluffy white rabbit all over Chris Kilham's body, murmuring in Quechua, the language of these barren plains. Then she slits the animal's throat and lets the blood run into a tiny grave.

To Kilham, the offering — an appeal to the gods for a bountiful harvest of maca, a local tuber — is just another day at the office.

Part David Attenborough, part Indiana Jones, Kilham, an ethnobotanist from Massachusetts who calls himself the Medicine Hunter, has scoured remote jungles and highlands for three decades for plants, oils and extracts that can heal. He has eaten bees and scorpions in China, fired blow guns with Amazonian natives, and learned traditional war dances from Pacific Islanders.

But behind the colorful tales lies the prospect of money, lots of money — for Western pharmaceutical companies, impoverished indigenous tribes and Kilham.

Products that once seemed exotic, like ginseng, ginkgo biloba or aloe vera, now roll off the tongues of Westerners. All told, natural plant substances generate more than $75 billion in sales each year for the pharmaceutical industry, $20 billion in herbal supplement sales, and around $3 billion in cosmetics sales, according to a study by the European Commission.

Although the efficacy of some of the products the herbal ingredients go into is hotly debated, their popularity is not in doubt. Thirty-six percent of adults in the United States use some form of what experts call complementary and alternative medicine, CAM for short, according to a 2004 study published by the National Center for Complementary and Alternative Medicine, a division of the National Institutes of Health.

Kilham believes multinational drug companies underutilize the medicinal properties in plants. They pack pills with artificial compounds and sell them at huge markups, he says. He wants Westerners to use the pure plant medicines that indigenous peoples have used for thousands of years.

"People in the U.S. are more cranked up on pharmaceutical drugs than any other culture in the world today," Kilham said. "I want people using safer medicine. And that means plant medicine."

Easy going and earnest, Kilham, 55, caught the plant bug after taking an herb walk at an organic farm in Natick, Massachusetts, in 1971. A self-described hippie, he was already into "yoga, natural foods and meditation" and the discovery that plants had medicinal properties had a profound effect. He created a course in holistic health at the University of Massachusetts at Amherst, where he is now on the faculty, and made his first overseas trip — to India — to track down exotic flora.

Now he can identify unusual plants by their Latin names and he proudly regales the uninitiated on their individual properties. Shortly after leaving Lima on a trip taking French businessmen to the Peruvian Andes, he stopped the van and enthusiastically explained how the tropane alkaloids in a dusty plant he spotted by the side of the road are used by ophthalmologists to dilate pupils for eye examinations.

Such properties are often well known by indigenous peoples. So-called bioprospectors can make their fortunes by bringing those advantages to the attention of companies who identify the plant's active compound and use it as a base ingredient for new products that they patent.

Some 62 percent of all cancer drugs approved by the Food and Drug Administration come from such discoveries, according to a study by the United Nations University, a scholarly institution affiliated with the United Nations.

"Latin American nations, especially Amazonian nations, have extremely rich and diverse flora, so the potential for commercial applications appears great," said Tony Gross, a Brazil-based researcher at the university. "They say that in one in 10,000 you get something interesting. So it is not a gold mine, but when you do hit on something that does become a market leader you can make enormous amounts of money from it."

In Peru, Kilham is betting on maca, a small root vegetable that grows here in the central highlands — "a turnip that packs a punch," he says, adding "it imparts energy, sex drive and stamina like nothing else."

That view is supported by studies carried out at the International Potato Center, a Lima-based research center that is internationally financed and staffed. Studies there show maca improves stamina, reduces the risk of prostate cancer and increases the motility, volume and quality of sperm.

Some peer reviewed studies published in the journal Reproductive Biology and Endocrinology backed up those findings.

For centuries, maca has been a revered crop in this austerely beautiful region 155 miles northeast of Lima. Inca warriors ate it before going into battle. Later, Peruvians used it to pay taxes to Spanish conquistadors.

Today, locals consume it boiled alongside dried vicuña meat in soups; or diced with carrots, peas and cauliflowers in salads. Maca flour is used to make sponge cake. Flavored with chocolate, it is made into maca puffs. Villagers offer visitors maca drinks and maca juice; airports sell maca toffees.

Kilham first heard about the tuber in 1996. Two years later, he went to Peru to find out more. There he formed a partnership with Sergio Cam, a Peruvian entrepreneur who invested much of the money he made as a construction worker in California from 1984 to 1999 to start Chakarunas Trading. The company is named after the Quechua word for men who build bridges between cultures.

Today, Chakarunas organizes local growers to sell their maca to the French firm Naturex, which extracts it into concentrate. Naturex sells the concentrate to Enzymatic Therapy, a Wisconsin-based company that makes and markets the finished maca products.

Thanks to the health supplements boom, both companies have grown, with Naturex's revenues topping $125 million in 2007 and Enzymatic Therapy's surpassing $80 million. Enzymatic Therapy sells $200,000 worth of maca-based products each month, said the company's chief executive Randy Rose.

One product, Maca Stimulant, is sold in Wal-Mart under Kilham's Medicine Hunter brand. Kilham earns a retainer from both Naturex and Enzymatic Therapy, in addition to royalties from another Medicine Hunter-branded product at Wal-Mart.

Kilham says he earns around $200,000 each year in retainers, and sales are so buoyant he expects to make "in the mid-six figures" in royalties next year.

Kilham insists he is not in the business simply for financial gain. His motivation comes from promoting herbal medicines and helping traditional communities, he said.

"I have financial security and don't need to make money from this," he said. "I believe trade is the best way to get good medicines to the public, to help the environment and to help indigenous people."

He and Cam pay growers here in Ninacaca a premium of 6 soles (about $2) for a kilo of maca, almost twice the going rate of 3 to 3.40 soles a kilo. They have set up a computer room at the Chakarunas warehouse and a free dental clinic, the town's first.

Kilham is clearly adored by the locals in these desolate, wind-swept villages. On a recent visit here, shamans, maca growers and their families flocked to him. Since only maca and potatoes grow at this altitude, they are thankful Kilham is helping them sell their produce.

He makes a point of returning regularly to Peru to affirm his commitment to the project. On this trip, his third this year, he brought executives from Phythea, a French company that sold 40 million euros of natural products last year. Phythea's president, Laurent Mallet, had heard about maca and wanted to see both the agricultural and social aspect of Chakarunas Trading up close.

Mallet said he was so touched by the people and the rawness of their surroundings — it took him seven hours by van to get here, and several doses of oxygen to offset the headaches and nausea brought on by the altitude — that he vowed to increase his order of maca from five to 25 tons next year, if clinical trials in Bordeaux confirmed that maca reduces hot flushes and night sweats in menopausal women.

"I think it could be a very good product for us," Mallet said. "I especially like the human dimension. They want to build a school and a medical center."

To be sure, not everyone is so positive. Kilham runs the constant risk of being branded a "biopirate," an outsider who steals traditional knowledge and fails to pass on the benefits to the local community.

In 2001, the company Kilham worked for at the time, Pure World Botanics, obtained United States patents for isolating and extracting maca's key active compounds. The Peruvian government accused the company of profiting from what was rightfully Peru's.

Kilham said he fought to make his bosses open up the patents. The company denied they had acted improperly but Naturex, which bought Pure World Botanics in 2005, granted Peruvian companies free licenses to the patents and vowed to increase the price paid per kilo to maca farmers by 15 percent.

Mars 2008: A Red Planet Odyssey

Mars Global Surveyor
Mars Global Surveyor
This artist rendering shows the Mars Global Surveyor in orbit around the Red Planet. The Surveyor is just one of a host of instruments studying Mars for signs of water and the organic building blocks necessary for life.

At the tail of 2007, the intrepid robotic explorer
Spirit was beating a path to a safe spot to spend the Martian winter. It was a hard year, and the small, six-wheeled rover still bears the scars of a planet-wide dust storm that nearly ended its mission.

Spirit and a twin named Opportunity have been pawing the dead Mars terrain for signs of past water, a key factor in scientists' ongoing quest to determine if Earth's neighbor ever hosted life.

The dust storm left Spirit so caked with debris that sunlight has a hard time getting through to the solar power cells that charge the rover's batteries. The past three weeks were particularly tense because the sun is not rising very high in the sky as the planet's southern hemisphere pivots into winter.

Still Going, and Going

But Spirit, which has already defied the odds, pulled through again, settling onto a northern-facing slope of a rock formation known as Home Plate in Gusev Crater. That it continues to operate at all, four years after arriving on Mars for what was designed to be a three-month mission, is most surprising.

Spirit's prowess has been matched by sister rover Opportunity, which is exploring a crater halfway around the planet. The dust storm shut it down for weeks as well, but Opportunity recovered quicker thanks to brisk winds that instead of depositing more sand blew its solar panels clean.

"The fact that these two rovers are going on their fourth year is amazing," said Mars researcher Ray Arvidson with Washington University in St. Louis.

Both rovers found mineralogical evidence that Mars had water on or near its surface at some point in its past. They will continue to pry out secrets even as scientists prepare for their first direct look at what remains of the planet's water today.

On May 25, a new probe named Phoenix is due to touch down on Mars' unexplored north pole. Its landing spot has been carefully selected and timed to coincide with the seasonal spring thaw. Scientists are counting on scratching through the ground cover and finding what may be a thick layer of water ice beneath the frozen surface.

"The first major discovery we think we'll see is ice," said Arvidson, a Phoenix co-investigator. After that, he added, "we don't know what we're going to find."

Phoenix will bake bits of Martian ice in tiny ovens to determine the isotopic composition of the water, information scientists can use to learn how recently the water was locked into the ground. If the isotopic ratios are similar to atmospheric composition, the water likely was a fairly recent phenomenon in a geologic sense, a mere 100,000 years old or so.

But if the ice samples show a disequilibrium with atmospheric measurements, then the water may be ancient, leftover remains of a long-vanished sea.

Either scenario, however, would reveal new details of Mars' evolution.

"We've never actually sampled the ice. We've never been that far north," Arvidson said.

Phoenix's science instruments will also hunt for organic molecules in the ice and soil. Organics, like water, are believed to be key for life to evolve.

"We're not going to have life or conditions suitable to have life unless we can make organic compounds and conserve them," Arvidson said.

Bird's Eye View

In addition to the surface robots, Mars will be studied from on high as well. Three orbiters -- Mars Odyssey, Mars Reconnaissance Orbiter and the European Space Agency's Mars Express -- are operating to photograph, map and chemically analyze the planet from the vantage point of space.

In addition to geologic signs of water, such as dried channels and riverbeds, the orbiters have instruments to find minerals associated with the presence of water, such as clays. The information is helping scientists hone in on potential habitats for past or present-day life and lay the foundations for a sample return mission around 2020.

In 2008, NASA will be narrowing down or even selecting a landing site for a sophisticated rover called Mars Science Laboratory that will analyze rocks and soil for signs of organic matter and environmental conditions suitable for life. MSL's launch is scheduled for 2009.

Also in 2008, NASA will select an atmospheric monitoring probe, which may be able to pinpoint areas on the planet's surface that are emitting methane, a chemical, which on Earth, has strong associations with organic matter and life.

"We're taking steps to efficiently explore this planet," Arvidson said. "By the end of the next decade, we'll have a much better understanding of the overall evolution of Mars and the role of water. If we're lucky, we may have evidence of past life or life today." 

Calendar
04 2024/05 06
S M T W T F S
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
Timepiece
タグホイヤー フォーミュラー1 ドリームキャンペーン
Blog Plus
SEO / RSS
Podcast
by PODCAST-BP
New TB
Bar Code
Data Retrieval
Oldest Articles
(09/30)
(09/30)
(09/30)
(09/30)
(09/30)
Photo Index
Reference
Latina




RSS Reader
無料RSSブログパーツ
Misc.
◆BBS


◆Chat


◆Micro TV


Maps



顔文字教室




Copyright © Info All Rights Reserved.
Powered by NinjaBlog
Graphics by 写真素材Kun * Material by Gingham * Template by Kaie
忍者ブログ [PR]